Detalhe da pesquisa
1.
Second hematopoietic stem cell transplantation as salvage therapy for relapsed acute myeloid leukemia/myelodysplastic syndromes after a first transplantation.
Haematologica
; 108(7): 1782-1792, 2023 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36475520
2.
The occurrence of thrombosis during intensive chemotherapy treatment for acute myeloid leukemia patients does not impact on long-term survival.
Ann Hematol
; 102(5): 1037-1043, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-36905445
3.
Venetoclax-based salvage therapy for adult patients with relapsed/refractory acute lymphoblastic leukemia.
Eur J Haematol
; 111(3): 365-372, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37254665
4.
Defining Current Patterns of Blood Product Use during Intensive Induction Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia Patients.
Transfus Med Hemother
; 50(5): 456-468, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37899992
5.
ELN 2017 classification significantly impacts the risk of early death in acute myeloid leukemia patients receiving intensive induction chemotherapy.
Ann Hematol
; 101(2): 309-316, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34989829
6.
Evaluating outcomes of adult patients with acute lymphoblastic leukemia and lymphoblastic lymphoma treated on the GMALL 07/2003 protocol.
Ann Hematol
; 101(3): 581-593, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35088172
7.
Gilteritinib monotherapy for relapsed/refractory FLT3 mutated acute myeloid leukemia: a real-world, multi-center, matched analysis.
Ann Hematol
; 101(9): 2001-2010, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35739428
8.
Contemporary evaluation of acute myeloid leukemia patients with long-term survival exceeding 5 years.
Eur J Haematol
; 109(6): 765-771, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36128925
9.
Cytogenetic risk classification maintains its prognostic significance in transplanted FLT3-ITD mutated acute myeloid leukemia patients: On behalf of the acute leukemia working party/European society of blood and marrow transplantation.
Am J Hematol
; 97(3): 274-282, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34978724
10.
Outcome of T-cell-replete haploidentical stem cell transplantation improves with time in adults with acute lymphoblastic leukemia: A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Cancer
; 127(14): 2507-2514, 2021 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33739471
11.
A phase II study of bisantrene in patients with relapsed/refractory acute myeloid leukemia.
Eur J Haematol
; 106(2): 260-266, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33159365
12.
Venetoclax combinations induce high response rates in newly diagnosed acute myeloid leukemia patients ineligible for intensive chemotherapy in routine practice.
Am J Hematol
; 96(7): 790-795, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33836555
13.
Complete Remission with Incomplete Blood Count Recovery Is a Strong Predictor of Nonrelapse Mortality in Acute Myeloid Leukemia Patients Undergoing Allogeneic Stem Cell Transplantation.
Acta Haematol
; 144(6): 613-619, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34102632
14.
Cytogenetic risk score maintains its prognostic significance in AML patients with detectable measurable residual disease undergoing transplantation in remission: On behalf of the acute leukemia working party of the European society for blood and marrow transplantation.
Am J Hematol
; 95(10): 1135-1141, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32530520
15.
Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients Age >69 Years with Acute Myelogenous Leukemia: On Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Biol Blood Marrow Transplant
; 25(10): 1975-1983, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31181255
16.
Two-dimensional speckle-tracking strain detects subclinical cardiotoxicity in older patients treated for acute myeloid leukemia.
Echocardiography
; 36(11): 2033-2040, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31705570
17.
Minimal residual disease status predicts outcome of acute myeloid leukaemia patients undergoing T-cell replete haploidentical transplantation. An analysis from the Acute Leukaemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT).
Br J Haematol
; 183(3): 411-420, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30117144
18.
Donor age determines outcome in acute leukemia patients over 40 undergoing haploidentical hematopoietic cell transplantation.
Am J Hematol
; 93(2): 246-253, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29114918
19.
T-cell replete haploidentical stem cell transplantation attenuates the prognostic impact of FLT3-ITD in acute myeloid leukemia: A report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Am J Hematol
; 93(6): 736-744, 2018 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-29498106
20.
Impact of ABO incompatibility on patients' outcome after haploidentical hematopoietic stem cell transplantation for acute myeloid leukemia - a report from the Acute Leukemia Working Party of the EBMT.
Haematologica
; 102(6): 1066-1074, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28255020